Stimpod ST2-3010 Nerve Stimulator
Stimulator, Nerve, Battery-Powered. 510(k) K140853, from Xavant Technology (Pty), Ltd. (Pretoria, Gauteng, ZA). Product code BXN, class 2.
As of Nov 17, 2026, K140853 is an FDA 510(k) held by Xavant Technology (Pty), Ltd., substantially equivalent on Nov 6, 2014 after 217 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 6, 2014
- Review time: 217 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe STIMPOD ST2-3010 is a nerve stimulation device designed to be used for the purpose of nerve locating using invasive electrodes or needles (not supplied)
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Stimpod NMS450 Nerve StimulatorK102084 · Xavant Technology (Pty), Ltd. · Dec 16, 2010
Other BXN Clearances
The newest 510(k)s for the same product code; see every BXN device- STIMPOD NMS450 Nerve StimulatorK213049 · Xavant Technology (Pty), Ltd. · Oct 16, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 3, 2014
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.2775
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files